Harp Diagnostics

Remote & rapid monitoring platform for superior disease management of IBD and other GI conditions

Health Tech & Life Sciences
Active
Seed Founded 2022
Total raised
Last: Seed 2023-02
Stage
Seed
Founded
2022
Headcount
2
HQ
Sector
Health Tech & Life Sciences

About

HARP Diagnostics is developing the world’s first automated, user-friendly and rapid, stool testing platform for home monitoring of gastrointestinal conditions, like Inflammatory Bowel Diseases - IBD (Crohn’s and Colitis). The platform offers an end-to-end solution, from seamless & user-friendly sample collection (with no direct contact with the stool sample) to rapid and accurate results, with built-in safeguards to eliminate human error. The patented portable device can be used by patients from the comfort of their home, or by healthcare providers at the doctors office (point-of-care) - with no mess, no user error. It is designed to be user-friendly and fail-safe even for people with no training, ensuring more patients test themselves regularly and easily. Test data is shared with the doctor through a cloud-connected system, helping to make better, real-time data-driven decisions about treatment adjustments of the chronic patients, dramatically improving continuity of care and long-term outcomes, while reducing healthcare related costs.

HARP is the winner of the 2025 IBD Shark Tank Competition of the American Chron’s and Colitis Foundation.

Funding history · 1 round · — total

2023-02
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

crohn-s-diseasemonitoringmedical-devicesdisease-managementhome-caregastroenterologyinflammatory-diseasesdigital-healthcaretelemedicineremote-monitoring